淀粉样变-话题@MedSci

#淀粉样变#

95篇内容 | 3244人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1405200, encodeId=0cc2140520087, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性, objectType=article, longId=215363, objectId=58cb215363aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58cb215363aa, replyNumber=0, likeNumber=91, createdTime=2021-08-07, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58cb215363aa, moduleTitle=NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58cb215363aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405199, encodeId=b293140519998, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Brain-血浆胶质纤维酸性蛋白，可反映阿尔兹海默的淀粉样变化, objectType=article, longId=214386, objectId=6e53214386ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e53214386ae, replyNumber=0, likeNumber=71, createdTime=2021-07-20, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e53214386ae, moduleTitle=Brain-血浆胶质纤维酸性蛋白，可反映阿尔兹海默的淀粉样变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e53214386ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405198, encodeId=941e140519829, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Birtamimab治疗Mayo IV期AL淀粉样变性，将进行验证性III期AFFIRM-AL研究, objectType=article, longId=206692, objectId=8638206692c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8638206692c1, replyNumber=0, likeNumber=58, createdTime=2021-02-04, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8638206692c1, moduleTitle=Birtamimab治疗Mayo IV期AL淀粉样变性，将进行验证性III期AFFIRM-AL研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8638206692c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405197, encodeId=fe68140519e98, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Lancet Neurology：Patisiran治疗遗传性甲状腺素运载蛋白介导的多发性神经病性淀粉样变的长期安全性和有效性结果 , objectType=article, longId=206032, objectId=5a4220603291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a4220603291, replyNumber=0, likeNumber=104, createdTime=2021-01-23, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a4220603291, moduleTitle=Lancet Neurology：Patisiran治疗遗传性甲状腺素运载蛋白介导的多发性神经病性淀粉样变的长期安全性和有效性结果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a4220603291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405196, encodeId=2aa714051967e, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Science子刊：天然Aβ抗体与阿尔茨海默病脑淀粉样变和认知功能的关系, objectType=article, longId=205370, objectId=65772053e095, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65772053e095, replyNumber=0, likeNumber=63, createdTime=2021-01-07, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65772053e095, moduleTitle=Science子刊：天然Aβ抗体与阿尔茨海默病脑淀粉样变和认知功能的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65772053e095)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405195, encodeId=a01c140519561, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Lancet Neurol：Patisiran治疗遗传性转甲状腺素蛋白淀粉样变性长期效果及安全性研究, objectType=article, longId=203514, objectId=468e203514a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=468e203514a5, replyNumber=0, likeNumber=86, createdTime=2020-11-19, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=468e203514a5, moduleTitle=Lancet Neurol：Patisiran治疗遗传性转甲状腺素蛋白淀粉样变性长期效果及安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=468e203514a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405194, encodeId=5eec140519422, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=辉瑞罕见病创新药维万心®在中国获批，助力转甲状腺素蛋白淀粉样变性心肌病治疗, objectType=article, longId=201889, objectId=bc0c20188974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0c20188974, replyNumber=0, likeNumber=71, createdTime=2020-10-11, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0c20188974, moduleTitle=辉瑞罕见病创新药维万心®在中国获批，助力转甲状腺素蛋白淀粉样变性心肌病治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0c20188974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405193, encodeId=a5751405193e7, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=强生提交Darzalex皮下注射剂新适应症上市申请，治疗轻链淀粉样变性, objectType=article, longId=200589, objectId=14462005895e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14462005895e, replyNumber=0, likeNumber=78, createdTime=2020-09-13, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14462005895e, moduleTitle=强生提交Darzalex皮下注射剂新适应症上市申请，治疗轻链淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14462005895e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405192, encodeId=407914051922f, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Can J Cardiol：加拿大声明，心脏淀粉样变合并心衰有5特征！, objectType=article, longId=199604, objectId=69a719960403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a719960403, replyNumber=0, likeNumber=112, createdTime=2020-08-19, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a719960403, moduleTitle=Can J Cardiol：加拿大声明，心脏淀粉样变合并心衰有5特征！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69a719960403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405191, encodeId=dec5140519135, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=NEJM：悬雍垂淀粉样变性-病例报道, objectType=article, longId=198847, objectId=9d3019884e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d3019884e0c, replyNumber=0, likeNumber=92, createdTime=2020-08-07, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d3019884e0c, moduleTitle=NEJM：悬雍垂淀粉样变性-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d3019884e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405190, encodeId=69e81405190d2, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=病例报道|以腹水为首发表现的肝淀粉样变性, objectType=article, longId=198243, objectId=af1e19824322, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af1e19824322, replyNumber=0, likeNumber=72, createdTime=2020-07-30, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af1e19824322, moduleTitle=病例报道|以腹水为首发表现的肝淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af1e19824322)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405189, encodeId=0e4114051897a, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=抗CD38抗体-药物偶联物（ADC）STI-6129治疗淀粉样变性：FDA已批准IND, objectType=article, longId=194877, objectId=616f1948e72f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616f1948e72f, replyNumber=0, likeNumber=63, createdTime=2020-05-29, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616f1948e72f, moduleTitle=抗CD38抗体-药物偶联物（ADC）STI-6129治疗淀粉样变性：FDA已批准IND, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=616f1948e72f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405188, encodeId=2ff6140518850, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Alnylam的RNAi疗法Vutrisiran获得FDA快速通道指定，治疗hATTR淀粉样变性, objectType=article, longId=192376, objectId=8eeb1923e6a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eeb1923e6a6, replyNumber=0, likeNumber=39, createdTime=2020-04-17, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eeb1923e6a6, moduleTitle=Alnylam的RNAi疗法Vutrisiran获得FDA快速通道指定，治疗hATTR淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8eeb1923e6a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405187, encodeId=6c04140518eb4, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Eur Heart J：TAVI患者中主动脉瓣狭窄和心脏淀粉样变性的患病率和预后, objectType=article, longId=191861, objectId=0c731918615a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c731918615a, replyNumber=0, likeNumber=93, createdTime=2020-04-11, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c731918615a, moduleTitle=Eur Heart J：TAVI患者中主动脉瓣狭窄和心脏淀粉样变性的患病率和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c731918615a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405186, encodeId=13f21405186ad, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Blood：达雷木单抗联合CyBorD治疗新确诊的AL淀粉样变, objectType=article, longId=191570, objectId=b83c1915e0cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b83c1915e0cc, replyNumber=0, likeNumber=75, createdTime=2020-04-08, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b83c1915e0cc, moduleTitle=Blood：达雷木单抗联合CyBorD治疗新确诊的AL淀粉样变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b83c1915e0cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405185, encodeId=a3f61405185c4, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=隐匿性气管淀粉样变性全身麻醉1例, objectType=article, longId=189246, objectId=6b1818924658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b1818924658, replyNumber=0, likeNumber=57, createdTime=2020-03-04, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b1818924658, moduleTitle=隐匿性气管淀粉样变性全身麻醉1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b1818924658)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405184, encodeId=b10b140518462, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Blood：Daratumumab单药疗法用于淀粉样变患者的疗效和安全性, objectType=article, longId=189096, objectId=c90418909689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c90418909689, replyNumber=0, likeNumber=102, createdTime=2020-03-03, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c90418909689, moduleTitle=Blood：Daratumumab单药疗法用于淀粉样变患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c90418909689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405183, encodeId=1f731405183fd, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=辉瑞的Vyndaqel首次在欧洲获批用于治疗淀粉样变心肌病ATTR-CM, objectType=article, longId=188474, objectId=ccaa1884e403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccaa1884e403, replyNumber=0, likeNumber=83, createdTime=2020-02-22, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccaa1884e403, moduleTitle=辉瑞的Vyndaqel首次在欧洲获批用于治疗淀粉样变心肌病ATTR-CM, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccaa1884e403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405182, encodeId=3a281405182e6, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=JACC：PET可以预测心肌淀粉样变性患者的预后, objectType=article, longId=188127, objectId=4d9a18812e75, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d9a18812e75, replyNumber=0, likeNumber=83, createdTime=2020-02-16, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d9a18812e75, moduleTitle=JACC：PET可以预测心肌淀粉样变性患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d9a18812e75)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405181, encodeId=a775140518127, content=<a href='/topic/show?id=cb6e6591850' target=_blank style='color:#2F92EE;'>#淀粉样变#</a>, objectTitle=Blood：达雷木单抗治疗AL淀粉样变的疗效和安全性, objectType=article, longId=187137, objectId=3fb318e137da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fb318e137da, replyNumber=0, likeNumber=49, createdTime=2020-02-03, rootId=0, userName=xjy03, userId=2ca02527521, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fb318e137da, moduleTitle=Blood：达雷木单抗治疗AL淀粉样变的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fb318e137da)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淀粉样变

2020-05-29

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性

2021-08-07

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Brain-血浆胶质纤维酸性蛋白，可反映阿尔兹海默的淀粉样变化

2021-07-20

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Birtamimab治疗Mayo IV期AL淀粉样变性，将进行验证性III期AFFIRM-AL研究

2021-02-04

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Lancet Neurology：Patisiran治疗遗传性甲状腺素运载蛋白介导的多发性神经病性淀粉样变的长期安全性和有效性结果

2021-01-23

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Science子刊：天然Aβ抗体与阿尔茨海默病脑淀粉样变和认知功能的关系

2021-01-07

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Lancet Neurol：Patisiran治疗遗传性转甲状腺素蛋白淀粉样变性长期效果及安全性研究

2020-11-19

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

辉瑞罕见病创新药维万心®在中国获批，助力转甲状腺素蛋白淀粉样变性心肌病治疗

2020-10-11

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

强生提交Darzalex皮下注射剂新适应症上市申请，治疗轻链淀粉样变性

2020-09-13

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Can J Cardiol：加拿大声明，心脏淀粉样变合并心衰有5特征！

2020-08-19

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

NEJM：悬雍垂淀粉样变性-病例报道

2020-08-07

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

病例报道|以腹水为首发表现的肝淀粉样变性

2020-07-30

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

抗CD38抗体-药物偶联物（ADC）STI-6129治疗淀粉样变性：FDA已批准IND

2020-05-29

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Alnylam的RNAi疗法Vutrisiran获得FDA快速通道指定，治疗hATTR淀粉样变性

2020-04-17

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Eur Heart J：TAVI患者中主动脉瓣狭窄和心脏淀粉样变性的患病率和预后

2020-04-11

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Blood：达雷木单抗联合CyBorD治疗新确诊的AL淀粉样变

2020-04-08

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

隐匿性气管淀粉样变性全身麻醉1例

2020-03-04

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Blood：Daratumumab单药疗法用于淀粉样变患者的疗效和安全性

2020-03-03

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

辉瑞的Vyndaqel首次在欧洲获批用于治疗淀粉样变心肌病ATTR-CM

2020-02-22

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

JACC：PET可以预测心肌淀粉样变性患者的预后

2020-02-16

xjy03 (审核中...)

前往app查看评论内容

#淀粉样变#

Blood：达雷木单抗治疗AL淀粉样变的疗效和安全性

2020-02-03

科室
- - 订阅+
  - 更多科室
工具
服务